CollPlant Biotechnologies Ltd. (CLGN) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 4 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for CLGN is $12.50, representing a +3,557.1% upside from the current price of $0.3418. Price targets range from a low of $11.00 to a high of $14.00.
